Irina Kostler
Investor Relations
Replay available
BioLineRx Ltd. (BLRX) Q3 2025 Earnings Call
BioLineRx Ltd. (NASDAQ: BLRX) Q3 2025 earnings conference call, held 2025-11-24. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Phil Serlin
Chief Executive Officer
Molly Zevi
Chief Financial Officer
Joe Pangenis
Analyst, HC Wainwright
Ella Serrani
Chief Development Officer
John Vandermosten
Analyst, Lux
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Biolinerx Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.098 -- 00:00:02.446 Ladies and gentlemen, thank you for standing by. 00:00:02.446 -- 00:00:06.212 The conference will begin shortly. 00:00:45.374 -- 00:00:48.417 Ladies and gentlemen, thank you for standing by. 00:00:48.417 -- 00:00:53.663 Welcome to the BioLine Rx third quarter 2025 financial results conference 00:00:53.663 -- 00:00:58.148 call. All participants are presently in a listen-only mode. 00:00:58.148 -- 00:01:02.492 Following management's formal presentation, instructions will be given for the question 00:01:02.492 -- 00:01:07.718 and answer session. For operator assistance during the conference, please press star 00:01:07.718 -- 00:01:12.087 zero. As a reminder, this conference is being recorded. 00:01:12.087 -- 00:01:17.134 I would now like to turn over the call to Irina Kostler, Investor Relations. 00:01:17.134 -- 00:01:19.257 Irina, please go ahead. 00:01:19.257 -- 00:01:22.382 Thank you, Operator, and welcome, everyone. 00:01:22.382 -- 00:01:26.748 Thank you for joining us on our quarterly results conference call. 00:01:26.748 -- 00:01:32.035 Earlier today, we issued a press release, a copy of which is available in the Investor 00:01:32.035 -- 00:01:38.108 Relations section of our website. It was also filed as a 6K. 00:01:38.108 -- 00:01:43.898 I'd like to remind you that certain statements we make during the call will be forward-looking. 00:01:43.898 -- 00:01:50.228 Because such statements deal with future events and are subject to many risks and uncertainties, 00:01:50.228 -- 00:01:55.076 actual results may differ materially from those in the forward-looking statements. 00:01:55.076 -- 00:02:00.285 For a full discussion of these risks and uncertainties, please review our annual 00:02:00.285 -- 00:02:06.005 report on Form 20F and our...